Association Study between Psoriatic Arthritis and Killer Immunoglobulin-Like Receptor (KIR) Genes: A Meta-Analysis

References

• Atzeni F, Defendenti C, Ditto MC, Batticciotto A, Ventura D, Antivalle M, Ardizzone S, Sarzi-Puttini P. 2014. Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev. 13(1):20–23.
   PubMed Web of Science ®Google Scholar
• Biassoni R, Malnati MS. 2018. Human natural killer receptors, co-receptors, and their ligands. Curr Protoc Immunol. 121(1):e47.
   PubMedGoogle Scholar
• Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD. 2014. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis. Rheumatology (Oxford). 53(2):233–39.
   PubMed Web of Science ®Google Scholar
• Coates LC, FitzGerald O, Helliwell PS, Paul C. 2016. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same? Semin Arthritis Rheum. 46(3):291–304.
   PubMed Web of Science ®Google Scholar
• Conigliaro P, Scrivo R, Valesini G, Perricone R. 2011. Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. Autoimmun Rev. 10(10):577–81.
   PubMed Web of Science ®Google Scholar
• Fathollahi A, Aslani S, Mostafaei S, Rezaei N, Mahmoudi M. 2018. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis. Inflamm Res. 67(9):727–36.
   PubMed Web of Science ®Google Scholar
• Fitzgerald O, Winchester R. 2009. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 11(1):214.
   PubMed Web of Science ®Google Scholar
• Haroon M, FitzGerald O. 2016. Psoriatic arthritis: complexities, comorbidities and implications for the clinic. Expert Rev Clin Immunol. 12(4):405–16.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ. 327(7414):557–60.
   PubMed Web of Science ®Google Scholar
• Holm SJ, Sakuraba K, Mallbris L, Wolk K, Ståhle M, Sánchez FO. 2005. Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. J Invest Dermatol. 125(4):721–30.
   PubMed Web of Science ®Google Scholar
• Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. 2006. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 11(2):193–206.
   PubMed Web of Science ®Google Scholar
• Husni ME. 2015. Comorbidities in psoriatic arthritis. Rheum Dis Clin North Am. 41(4):677–98.
   PubMed Web of Science ®Google Scholar
• Kerschbaumer A, Fenzl KH, Erlacher L, Aletaha D. 2016. An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets. Wien Klin Wochenschr. 128(21–22):791–95.
   PubMed Web of Science ®Google Scholar
• Kuijpers TW, Vendelbosch S, Berg MV, Baeten DL. 2016. Killer immunoglobulin receptor genes in spondyloarthritis. Curr Opin Rheumatol. 28(4):368–75.
   PubMed Web of Science ®Google Scholar
• Kuśnierczyk P. 2013. Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Front Immunol. 4:8.
   PubMed Web of Science ®Google Scholar
• Lanier LL. 2005. NK cell recognition. Annu Rev Immunol. 23:225–74.
   PubMed Web of Science ®Google Scholar
• Lanier LL. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 9:495–502.
   PubMed Web of Science ®Google Scholar
• Lin L, Ma C, Wei B, Aziz N, Rajalingam R, Yusung S, Erlich HA, Trachtenberg EA, Targan SR, McGovern DP, et al. 2014. Human natural killer cells licensed by KIR genes have an altered cytokine program that modifies CD4+ T cell function. J Immunol. 193(2):940–49.
   PubMed Web of Science ®Google Scholar
• Liu SL, Zheng AJ, Ding L. 2017. Association between KIR gene polymorphisms and type 1 diabetes mellitus (T1DM) susceptibility: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 96(52):e9439.
   PubMed Web of Science ®Google Scholar
• Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, Wilson MJ, Trowsdale J, Gladman D, Carrington M. 2002. Cutting edge: susceptibility to psoriatic arthritis: influence of activating Killer Ig-Like Receptor genes in the absence of specific HLA-C alleles. J Immunol. 169(6):2818–22.
   PubMed Web of Science ®Google Scholar
• Massari D, Prpic-Massari L, Kehler T, Kastelan M, Curkovic B, Persic V, Ruzic A, Laskarin G. 2012. Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis. Rheumatol Int. 32(9):2777–84.
   PubMed Web of Science ®Google Scholar
• McQueen FM, Skinner MA, Krissansen GW, Robinson E, Tan PL. 1994. Natural killer cell function and expression of beta 7 integrin in psoriatic arthritis. J Rheumatol. 21(12):2266–73.
   PubMed Web of Science ®Google Scholar
• Napolitano M, Testa A, Ferrillo M, Villani A, Balato N, Megna M, Nardone OM, Fabbrocini G, Castiglione F. 2019. Psoriasis features in patients with inflammatory bowel disease. J Med Sci. 7(6):1001–03.
   Google Scholar
• Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. 2004. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Iglike receptor combinations in psoriatic arthritis. J Immunol. 173(7):4273–76.
   PubMed Web of Science ®Google Scholar
• Nemoto K, Muto M. 2011. Genotyping of human killer cell immunoglobulin-like receptor genes in Japanese patients with psoriatic arthritis, generalized pustular psoriasis or psoriasis vulgaris.. Bull Yamaguchi Med Sch. 58(3–4):37–43.
   Google Scholar
• Ostensen M, Førre O. 1988. Modulation of human natural killer cell function by cytokines and rheumatic disease. Scand J Rheumatol Suppl. 76:183–88.
   PubMedGoogle Scholar
• Pollock RA, Pellett FJ, Chandran V, Gladman DD. 2011. Expression patterns of natural killer receptor genes in inflamed joints and peripheral blood of patients with psoriatic arthritis. Tissue Antigens. 78(5):345–47.
   PubMedGoogle Scholar
• Pradana KA, Widjaya MA, Wahjudi M. 2019. Indonesians Human Leukocyte Antigen (HLA) distributions and correlations with global diseases. Immunol Invest. 24:1–31.
   Web of Science ®Google Scholar
• Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO. 2006. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 4(1):e9.
   PubMed Web of Science ®Google Scholar
• Rezaei R, Mostafaei S, Aslani S, Jamshidi A, Mahmoudi M. 2018. Association study between killer immunoglobulin-like receptor polymorphisms and ankylosing spondylitis disease: an updated meta-analysis. Int J Rheum Dis. 21(10):1746–55.
   PubMed Web of Science ®Google Scholar
• Ritchlin CT. 2005. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol. 17(4):406–12.
   PubMed Web of Science ®Google Scholar
• Ritchlin CT, Colbert RA, Gladman D. 2017. Psoriatic Arthritis. N Engl J Med. 376(10):957–70.
   PubMed Web of Science ®Google Scholar
• Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, Marmon S, Neimann A, Brusca S, Patel T, et al. 2015. Decreased bacterial diversity characterizes an altered gut microbiota in psoriatic arthritis and resembles dysbiosis of inflammatory bowel disease. Arthritis Rheumatol. 67(1):128–39.
   PubMed Web of Science ®Google Scholar
• Sen R, Hurley JA (2019). Seronegative Spondyloarthropathy. [dataset]. StatPearls Publishing [published 2019 Apr 4. accessed 2019 June 1]. https://www.ncbi.nlm.nih.gov/books/NBK459356/.
   Google Scholar
• Shahsavar F, Mapar S, Ahmadi SA. 2016. Multiple sclerosis is accompanied by lack of KIR2DS1 gene: A meta-analysis. Genom Data. 10:75–78.
   PubMedGoogle Scholar
• Spadaro A, Scrivo R, Moretti T, Bernardini G, Riccieri V, Taccari E, Strom R, Valesini G. 2004. Natural killer cells and gamma/delta T cells in synovial fluid and in peripheral blood of patients with psoriatic arthritis. Clin Exp Rheumatol. 22(4):389–94.
   PubMed Web of Science ®Google Scholar
• Stang A. 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25(9):603–05.
   PubMed Web of Science ®Google Scholar
• Suurmond R, Van Rhee H, Hak T. 2017. Introduction, comparison, and validation of Meta-Essentials: a free and simple tool for meta-analysis. Res Synth Methods. 8(4):537–53.
   PubMed Web of Science ®Google Scholar
• Veale DJ, Fearon U. 2018. The pathogenesis of psoriatic arthritis. Lancet. 391(10136):2273–84.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’connell D. 2012. Data from: the Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute, Ontario, Canada [accessed 2019 Apr]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Williams F, Meenagh A, Sleator C, Cook D, Fernandez-Vina M, Bowcock AM, Middleton D. 2005. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol. 66(7):836–41.
   PubMed Web of Science ®Google Scholar